Want to see JP:9341 full AI Analyst Report?
9341 Stock Chart & Stats
¥582.00
-¥9.00(-0.65%)
At close: 4:00 PM EST
¥582.00
-¥9.00(-0.65%)
Day’s Range― - ―
52-Week Range¥541.00 - ¥752.00
Previous CloseN/A
Volume164.20K
Average Volume (3M)127.01K
Market Cap
¥11.04B
Enterprise Value¥5.46B
Total Cash (Recent Filing)¥5.32B
Total Debt (Recent Filing)¥735.71M
Price to Earnings (P/E)38.9
Beta0.96
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.3%
Share Statistics
EPS (TTM)15.88
Shares Outstanding17,838,100
10 Day Avg. Volume126,090
30 Day Avg. Volume127,006
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)1.38
Price to Sales (P/S)0.82
P/FCF Ratio-202.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)157.5
Revenue Forecast (FY)¥15.40B
Bulls Say, Bears Say
Bulls Say
Strong Multi-year Revenue GrowthGENOVA's sustained ~24% revenue growth in 2026 and multi-year expansion indicates durable demand for its healthcare information services. Strong top-line momentum supports reinvestment in products, scale economies and market-share gains, reducing execution risk over the medium term.
Conservative Capital StructureA low debt-to-equity profile gives GENOVA financial flexibility to fund strategic investments or withstand cyclical downturns without heavy refinancing. Conservative leverage reduces solvency risk and preserves optionality to deploy capital for growth or to shore up cash during adverse operating periods.
Asset Growth Supporting ScaleConsistent asset growth suggests management has been reinvesting to expand capacity and capabilities. A larger asset base can enable broader service offerings, operational scale, and better absorption of fixed costs, supporting medium-term competitiveness despite margin variability.
Bears Say
Material Cash-flow DeteriorationA sharp reversal to weak operating cash flow and negative free cash flow undermines cash conversion and raises reliance on external funding. This constrains capital allocation, dividend sustainability and near-term reinvestment, and elevates liquidity risk if the cash shortfall persists.
Sharp Margin CompressionMaterial declines in gross, operating and net margins point to pricing pressure, cost inflation, or unfavorable mix. Sustained margin erosion reduces profitability, limits the firm's ability to self-fund growth, and raises the bar for operational improvements needed to restore prior earnings power.
Decline In Return On EquityA pronounced drop in ROE indicates weaker returns on the company's capital base and signals deteriorating earnings quality. If persistent, lower ROE diminishes shareholder returns, complicates capital allocation choices, and suggests structural or competitive issues beyond a short-term cycle.
GENOVA Inc. News
9341 FAQ
What was GENOVA Inc.’s price range in the past 12 months?
GENOVA Inc. lowest stock price was ¥541.00 and its highest was ¥752.00 in the past 12 months.
What is GENOVA Inc.’s market cap?
GENOVA Inc.’s market cap is ¥11.04B.
When is GENOVA Inc.’s upcoming earnings report date?
GENOVA Inc.’s upcoming earnings report date is Aug 10, 2026 which is in 25 days.
How were GENOVA Inc.’s earnings last quarter?
GENOVA Inc. released its earnings results on May 13, 2026. The company reported ¥12.96 earnings per share for the quarter, beating the consensus estimate of N/A by ¥12.96.
Is GENOVA Inc. overvalued?
According to Wall Street analysts GENOVA Inc.’s price is currently Overvalued.
Does GENOVA Inc. pay dividends?
GENOVA Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 5.3%. See more information on GENOVA Inc. dividends here
What is GENOVA Inc.’s EPS estimate?
GENOVA Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GENOVA Inc. have?
GENOVA Inc. has 17,838,100 shares outstanding.
What happened to GENOVA Inc.’s price movement after its last earnings report?
GENOVA Inc. reported an EPS of ¥12.96 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.185%.
Which hedge fund is a major shareholder of GENOVA Inc.?
Currently, no hedge funds are holding shares in JP:9341
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GENOVA Inc.
Operating within Japan, GENOVA, Inc. focuses on the digital healthcare market, providing both medical platform services and smart clinic solutions. Its offerings include Medical Doc, a comprehensive online platform that distributes diverse content, such as articles for healthcare institutions, patient experience narratives, treatment demonstrations, and general medical information. The company also developed Smart Clinic, an innovative telemedicine and consultation service that enables users to receive medical care from their homes or workplaces, bypassing the need for in-person hospital visits. Additionally, GENOVA offers a suite of clinic automation tools, including NOMOCa-Stand, a user-friendly automatic machine for reception and payments; NOMOCa-Regi, a dedicated self-pay terminal for clinic environments; and CLINIC BOT, an AI-driven chatbot system. GENOVA, Inc. was established in 2005 and is based in Tokyo, Japan.
Technical Analysis
Medley
―
―
Welby Inc.
―
Mental Health Technologies Co. Ltd.
―
Wellness Communications Corporation
―